McEvoy, the former leader of Johnson & Johnson’s medtech business, started immediately. Jim Hollingshead, who was CEO of ...

William Blair analyst Brandon Vazquez said 2025 could be the first year market leader Intuitive Surgical will face meaningful ...

While J&J, Abbott and Boston Scientific have all said the White House’s tariff policies will cost them hundreds of millions ...

An analysis of the timing of adverse event reports has convinced the company that raw material delivered by a vendor was the ...

Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart ...

Jon Monson, currently Boston Scientific's senior vice president for investor relations, will replace Brennan beginning June ...

The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of ...

CFO Jamie Samath cautioned that the trade environment, financial pressures on hospitals and macroeconomic risks could extend ...

Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...

Former Avanos Medical executive Michael Greiner has left the company. Greiner was CFO and chief transformation officer at the ...

The company is planning manufacturing footprint changes, supply chain adjustments, surcharges and cost cutting to limit the ...

One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but ...